MedTrace Logo

Pharmacokinetics of Carnosine

NCT00721708 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2009-12-15

No results posted yet for this study

Summary

The absorption kinetics of dietary carnosine (β-alanyl-L-histidine) will be determined in the healthy adults.

Conditions

  • Oxidative Stress

Interventions

DIETARY_SUPPLEMENT

pure carnosine

one time dose of pure carnosine (450 mg)

OTHER

Beef

one time dose, 150 g of beef

OTHER

Chicken

One time dose, 150g of chicken breast

OTHER

Chicken broth

one time dose of chicken broth obtained from 150g of chicken breast

Sponsors & Collaborators

  • Tufts University

    lead OTHER

Principal Investigators

  • Kyung-Jin Yeum, Ph.D. · Tufts Medical Center

Study Design

Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-10-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00721708 on ClinicalTrials.gov